Correlation Between Mustang Bio and Cytodyn
Can any of the company-specific risk be diversified away by investing in both Mustang Bio and Cytodyn at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mustang Bio and Cytodyn into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mustang Bio and Cytodyn, you can compare the effects of market volatilities on Mustang Bio and Cytodyn and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mustang Bio with a short position of Cytodyn. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mustang Bio and Cytodyn.
Diversification Opportunities for Mustang Bio and Cytodyn
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Mustang and Cytodyn is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Mustang Bio and Cytodyn in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytodyn and Mustang Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mustang Bio are associated (or correlated) with Cytodyn. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytodyn has no effect on the direction of Mustang Bio i.e., Mustang Bio and Cytodyn go up and down completely randomly.
Pair Corralation between Mustang Bio and Cytodyn
Given the investment horizon of 90 days Mustang Bio is expected to generate 4.14 times more return on investment than Cytodyn. However, Mustang Bio is 4.14 times more volatile than Cytodyn. It trades about 0.02 of its potential returns per unit of risk. Cytodyn is currently generating about 0.0 per unit of risk. If you would invest 143.00 in Mustang Bio on September 5, 2024 and sell it today you would lose (124.00) from holding Mustang Bio or give up 86.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Mustang Bio vs. Cytodyn
Performance |
Timeline |
Mustang Bio |
Cytodyn |
Mustang Bio and Cytodyn Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mustang Bio and Cytodyn
The main advantage of trading using opposite Mustang Bio and Cytodyn positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mustang Bio position performs unexpectedly, Cytodyn can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will offset losses from the drop in Cytodyn's long position.Mustang Bio vs. Checkpoint Therapeutics | Mustang Bio vs. Reviva Pharmaceuticals Holdings | Mustang Bio vs. Fortress Biotech Pref | Mustang Bio vs. Kodiak Sciences |
Cytodyn vs. Madrigal Pharmaceuticals | Cytodyn vs. Scpharmaceuticals | Cytodyn vs. Akero Therapeutics | Cytodyn vs. Cardiff Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |